HK1045334A1 - 缩氨酸受体结紮方法 - Google Patents

缩氨酸受体结紮方法 Download PDF

Info

Publication number
HK1045334A1
HK1045334A1 HK02106728.4A HK02106728A HK1045334A1 HK 1045334 A1 HK1045334 A1 HK 1045334A1 HK 02106728 A HK02106728 A HK 02106728A HK 1045334 A1 HK1045334 A1 HK 1045334A1
Authority
HK
Hong Kong
Prior art keywords
peptide acceptor
ligation methods
acceptor ligation
methods
peptide
Prior art date
Application number
HK02106728.4A
Other languages
English (en)
Chinese (zh)
Inventor
Kurz Markus
Lohse Peter
Wagner Richard
Original Assignee
Phylos, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phylos, Inc. filed Critical Phylos, Inc.
Publication of HK1045334A1 publication Critical patent/HK1045334A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02106728.4A 1999-07-27 2000-07-19 缩氨酸受体结紮方法 HK1045334A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14583499P 1999-07-27 1999-07-27
US145834P 1999-07-27
PCT/US2000/019653 WO2001007657A1 (en) 1999-07-27 2000-07-19 Peptide acceptor ligation methods

Publications (1)

Publication Number Publication Date
HK1045334A1 true HK1045334A1 (zh) 2002-11-22

Family

ID=22514769

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106728.4A HK1045334A1 (zh) 1999-07-27 2000-07-19 缩氨酸受体结紮方法

Country Status (16)

Country Link
US (3) US6429300B1 (cg-RX-API-DMAC7.html)
EP (2) EP1196637B1 (cg-RX-API-DMAC7.html)
JP (2) JP4766808B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020033743A (cg-RX-API-DMAC7.html)
AT (2) ATE360706T1 (cg-RX-API-DMAC7.html)
AU (2) AU781783B2 (cg-RX-API-DMAC7.html)
CA (2) CA2693274C (cg-RX-API-DMAC7.html)
CY (1) CY1113185T1 (cg-RX-API-DMAC7.html)
DE (1) DE60034566T2 (cg-RX-API-DMAC7.html)
DK (2) DK1196637T3 (cg-RX-API-DMAC7.html)
ES (2) ES2383332T3 (cg-RX-API-DMAC7.html)
HK (1) HK1045334A1 (cg-RX-API-DMAC7.html)
IL (1) IL147037A0 (cg-RX-API-DMAC7.html)
NO (1) NO20020348L (cg-RX-API-DMAC7.html)
PT (2) PT1196637E (cg-RX-API-DMAC7.html)
WO (1) WO2001007657A1 (cg-RX-API-DMAC7.html)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020033743A (ko) * 1999-07-27 2002-05-07 추후기재 펩티드 수용체 리게이션 방법
ATE356231T1 (de) 2000-01-11 2007-03-15 Nanogen Recognomics Gmbh Biomoleküle mit multiplen anbindungsabschnitten zur bindung an eine substratoberfläche
WO2001072998A2 (de) * 2000-03-31 2001-10-04 Memorec Stoffel Gmbh Verfahren zur extraktion von nukleinsäuren
WO2005072087A2 (en) * 2003-12-12 2005-08-11 Proteonova, Inc. System and methods for nucleic acid and polypeptide selection
US20040229271A1 (en) * 2000-05-19 2004-11-18 Williams Richard B. Compositions and methods for the identification and selection of nucleic acids and polypeptides
US7410761B2 (en) * 2000-05-19 2008-08-12 Proteonova, Inc. System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
US6962781B1 (en) * 2000-05-19 2005-11-08 Proteonova, Inc. In vitro evolution of nucleic acids and encoded polypeptide
AU2001295005A1 (en) * 2000-08-11 2002-02-25 Nanogen, Inc. Macromolecules having hydrazide attachment moieties and reagents for their production
US7129229B2 (en) 2000-08-11 2006-10-31 Nanogen Recognomics Gmbh Hydrazide building blocks and hydrazide modified biomolecules
JP4963142B2 (ja) * 2000-12-14 2012-06-27 学校法人慶應義塾 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
US20060234231A1 (en) * 2001-06-20 2006-10-19 Nuevolution A/S Microarrays displaying encoded molecules
WO2002102820A1 (en) * 2001-06-20 2002-12-27 Nuevolution A/S Nucleoside derivatives for library preparation
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
JP2004537312A (ja) * 2001-07-31 2004-12-16 フィロス インク． 核酸−蛋白質融合多量体のモジュラーアッセンブリ
DE10147074A1 (de) * 2001-09-25 2003-05-08 Beru Ag Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
AU2002356984A1 (en) * 2001-11-16 2003-06-10 Proteonova, Inc. Selection and evolution of nucleic acids and polypeptides
WO2003045975A2 (en) * 2001-11-27 2003-06-05 Compound Therapeutics, Inc. Solid-phase immobilization of proteins and peptides
DE20200926U1 (de) * 2002-01-23 2002-04-18 Hegenscheidt-MFD GmbH & Co. KG, 41812 Erkelenz Festwalzgerät einer Festwalzmaschine für Kurbelwellen
US20050247001A1 (en) * 2002-03-15 2005-11-10 Nuevolution A/S Building block forming a c-c or a c-hetero atom bond uponreaction
WO2003078626A2 (en) * 2002-03-15 2003-09-25 Nuevolution A/S A building block capable of transferring a functional entity
IL163822A0 (en) 2002-03-15 2005-12-18 Nuevolution As An improved method for synthesising templated molecules
US20050221318A1 (en) * 2002-03-15 2005-10-06 Gouliaev Alex H Building block forming a c-c bond upon reaction
US10730906B2 (en) 2002-08-01 2020-08-04 Nuevolutions A/S Multi-step synthesis of templated molecules
US20040058886A1 (en) * 2002-08-08 2004-03-25 Dharmacon, Inc. Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
ES2640279T3 (es) 2002-10-30 2017-11-02 Nuevolution A/S Procedimiento para la síntesis de un complejo bifuncional
US9121110B2 (en) 2002-12-19 2015-09-01 Nuevolution A/S Quasirandom structure and function guided synthesis methods
EP1597394A2 (en) * 2003-02-21 2005-11-23 Nuevolution A/S A method for obtaining structural information about an encoded molecule
US20070026397A1 (en) * 2003-02-21 2007-02-01 Nuevolution A/S Method for producing second-generation library
ATE424455T1 (de) * 2003-03-20 2009-03-15 Nuevolution As Ligationsvermittelnde codierung von kleinen molekülen
WO2004110964A2 (en) * 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
WO2005074417A2 (en) * 2003-09-03 2005-08-18 Salk Institute For Biological Studies Multiple antigen detection assays and reagents
US11118215B2 (en) * 2003-09-18 2021-09-14 Nuevolution A/S Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
BRPI0416201A (pt) * 2003-11-20 2006-12-26 Sanofi Pasteur Inc métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
EP1711196A4 (en) 2003-12-05 2011-09-14 Bristol Myers Squibb Co INHIBITORS OF TYPE-2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
EP1723255B1 (en) * 2004-02-17 2010-12-29 Nuevolution A/S Method for enrichment involving elimination by mismatch hybridisation
DK1730277T3 (da) * 2004-03-22 2010-03-01 Nuevolution As Kodning ved ligering under anvendelse af byggebloksoligonukleotider
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
JP4318721B2 (ja) * 2004-10-15 2009-08-26 独立行政法人科学技術振興機構 ｍＲＮＡ−ピューロマイシン−タンパク質連結体作製用リンカー
US20080199499A1 (en) 2005-01-12 2008-08-21 Proteonova, Inc. Method for Making Targeted Therapeutic Agents
US10206998B2 (en) 2005-01-12 2019-02-19 Proteonova, Inc. Modular targeted therapeutic agents and methods of making same
EP1951890A4 (en) 2005-11-16 2009-06-24 Ambrx Inc PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
ES2897529T3 (es) 2005-12-01 2022-03-01 Nuevolution As Métodos de codificación enzimática para la síntesis eficiente de bibliotecas grandes
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
JP5537946B2 (ja) 2006-11-22 2014-07-02 ブリストル−マイヤーズ スクイブ カンパニー Ｉｇｆ−ｉｒを含むチロシンキナーゼ受容体に対する改変タンパク質に基づく標的治療薬
WO2008100961A2 (en) 2007-02-12 2008-08-21 Proteonova, Inc. GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
CN101969971A (zh) 2007-11-30 2011-02-09 雅培制药有限公司 蛋白制剂及其制备方法
MX2010008874A (es) 2008-02-14 2010-09-22 Bristol Myers Squibb Co Terapeuticos dirigidos a base de proteinas manipuladas que se unen al receptor de factor de crecimiento epidermico.
EP2283132B1 (en) * 2008-05-02 2016-10-26 Epicentre Technologies Corporation Selective 5' ligation tagging of rna
EP2439212B1 (en) 2008-05-02 2016-12-21 Novartis AG Improved fibronectin-based binding molecules and uses thereof
EP2799448A1 (en) 2008-05-22 2014-11-05 Bristol-Myers Squibb Company Multivalent fibronectin based scaffold domain proteins
EP3629022A1 (en) * 2008-07-25 2020-04-01 Richard W. Wagner Protein screening methods
EP2342562B1 (en) * 2008-09-30 2013-09-18 AbbVie Inc. Improved method of rna display
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US20100158822A1 (en) 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
BRPI1014677A2 (pt) 2009-03-30 2016-04-12 Du Pont sistemas baseados em peptídeos para distribuição de agentes cosméticos
WO2010114638A1 (en) 2009-03-30 2010-10-07 E. I. Du Pont De Nemours And Company Peptide-based tooth whitening reagents
JP5733784B2 (ja) * 2009-09-24 2015-06-10 国立大学法人埼玉大学 ｃＤＮＡ／ｍＲＮＡ−タンパク質連結体の効率的合成法
WO2011051327A2 (en) 2009-10-30 2011-05-05 Novartis Ag Small antibody-like single chain proteins
WO2011051466A1 (en) 2009-11-02 2011-05-05 Novartis Ag Anti-idiotypic fibronectin-based binding molecules and uses thereof
WO2011092233A1 (en) 2010-01-29 2011-08-04 Novartis Ag Yeast mating to produce high-affinity combinations of fibronectin-based binders
IN2012DN06588A (cg-RX-API-DMAC7.html) 2010-02-10 2015-10-23 Novartis Ag
WO2011126370A1 (en) * 2010-04-09 2011-10-13 Universiteit Utrecht Holding B.V. Recombinant multimeric influenza proteins
WO2011127933A1 (en) 2010-04-16 2011-10-20 Nuevolution A/S Bi-functional complexes and methods for making and using such complexes
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
WO2011150133A2 (en) 2010-05-26 2011-12-01 Bristol-Myers Squibb Company Fibronectin based scaffold proteins having improved stability
MX345300B (es) 2010-07-30 2017-01-24 Novartis Ag * Moléculas andamio de fibronectina y bibliotecas de las mismas.
DE102010056289A1 (de) 2010-12-24 2012-06-28 Geneart Ag Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
EP2686349B1 (en) 2011-03-15 2020-12-09 X-Body, Inc. Antibody screening methods
SI2702146T1 (sl) 2011-04-28 2019-06-28 The Board Of Trustees Of The Leland Stanford Junior University Identifikacija polinukleotidov, povezanih z vzorcem
CA2843955A1 (en) 2011-08-01 2013-02-07 The General Hospital Corporation Protein and peptide libraries
EP2771022B1 (en) 2011-10-11 2020-07-01 Viela Bio, Inc. Cd40l-specific tn3-derived scaffolds and methods of use thereof
EP3712173B1 (en) 2011-12-05 2023-07-12 X-Body, Inc. Pdgf receptor beta binding polypeptides
JP6020865B2 (ja) 2013-03-13 2016-11-02 国立大学法人 東京大学 核酸リンカー
RU2678421C2 (ru) 2013-06-28 2019-01-28 Экс-Боди, Инк. Обнаружение антигена-мишени, фенотипический скрининг и его применение для идентификации специфичных эпитопов-мишеней клеток-мишеней
CN103382579B (zh) * 2013-07-06 2015-10-21 中国科学院成都生物研究所 一种体外筛选多肽的方法
ES2827281T3 (es) 2013-09-23 2021-05-20 X Body Inc Métodos y composiciones para la generación de agentes de unión contra antígenos de superficie celular
EP3090049B1 (en) * 2013-12-31 2017-10-18 F. Hoffmann-La Roche AG Enrichment of full-length oligonucleotides via transcription/translation-mediated purification
EP3102245B1 (en) 2014-02-05 2021-09-08 Molecular Templates, Inc. Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
ES2913840T3 (es) 2014-03-20 2022-06-06 Bristol Myers Squibb Co Dominios de tipo III de fibronectina de unión a seroalbúmina
JP6478392B2 (ja) * 2014-12-26 2019-03-06 国立研究開発法人産業技術総合研究所 核酸リンカー
CA2977675A1 (en) 2015-03-12 2016-09-15 Medimmune, Llc Method of purifying albumin-fusion proteins
ES2967078T3 (es) 2015-09-23 2024-04-25 Bristol Myers Squibb Co Dominios de fibronectina de tipo III de unión a seroalbúmina con velocidad de disociación rápida
KR102741603B1 (ko) 2016-05-02 2024-12-16 엔코디아, 인코포레이티드 암호화 핵산을 사용한 거대분자 분석
CA3027951A1 (en) * 2016-06-15 2017-12-21 Genecapture, Inc. Compositions, methods and devices comprising stem-loop captor molecules
CA3028002A1 (en) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
MA45491A (fr) 2016-06-27 2019-05-01 Juno Therapeutics Inc Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
RU2731211C1 (ru) 2017-03-21 2020-08-31 Фуджифилм Корпорэйшн Пептидное соединение и способ его получения, композиция для скринингового использования и способ отбора пептидного соединения
WO2019089836A1 (en) * 2017-10-31 2019-05-09 Encodia, Inc. Kits for analysis using nucleic acid encoding and/or label
US11807623B2 (en) 2017-11-30 2023-11-07 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
WO2019189591A1 (ja) * 2018-03-30 2019-10-03 住友化学株式会社 一本鎖ｒｎａの製造方法
WO2019236644A1 (en) * 2018-06-05 2019-12-12 Arrakis Therapeutics, Inc. Encoded libraries and methods of use for screening nucleic acid targets
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391723A (en) * 1989-05-31 1995-02-21 Neorx Corporation Oligonucleotide conjugates
US5843701A (en) * 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
WO1995011922A1 (en) * 1993-10-29 1995-05-04 Affymax Technologies N.V. In vitro peptide and antibody display libraries
DE19646372C1 (de) * 1995-11-11 1997-06-19 Evotec Biosystems Gmbh Genotyp und Phänotyp koppelnde Verbindung
US6143495A (en) * 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5842701A (en) * 1996-10-08 1998-12-01 Smith International, Inc. Dual functioning seal for rock bits
CA2268353A1 (en) 1996-10-10 1998-04-16 Henrik Garoff Alphavirus-retrovirus vectors
DE69739163D1 (de) * 1996-10-17 2009-01-22 Mitsubishi Chem Corp Molekül, welches Genotyp und Phänotyp zusammenführt und dessen Anwendungen
PT1712623E (pt) * 1997-01-21 2011-12-21 Gen Hospital Corp Selecção de proteínas utilizando fusões de arn-proteína
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US5935791A (en) * 1997-09-23 1999-08-10 Becton, Dickinson And Company Detection of nucleic acids by fluorescence quenching
AU750183B2 (en) * 1997-12-22 2002-07-11 Genset S.A. Prostate cancer gene
US5985575A (en) * 1998-05-20 1999-11-16 Wisconsin Alumni Research Foundation Tethered function assay for protein function
KR20020033743A (ko) * 1999-07-27 2002-05-07 추후기재 펩티드 수용체 리게이션 방법
US6436665B1 (en) * 1999-08-27 2002-08-20 Phylos, Inc Methods for encoding and sorting in vitro translated proteins

Also Published As

Publication number Publication date
CA2377468C (en) 2010-04-20
ES2383332T3 (es) 2012-06-20
CA2693274C (en) 2013-05-28
NO20020348D0 (no) 2002-01-23
IL147037A0 (en) 2002-08-14
US20020182687A1 (en) 2002-12-05
DE60034566T2 (de) 2008-01-03
EP1870417B1 (en) 2012-03-28
CA2377468A1 (en) 2001-02-01
AU6111200A (en) 2001-02-13
EP1870417A3 (en) 2008-06-11
ATE551352T1 (de) 2012-04-15
ATE360706T1 (de) 2007-05-15
ES2284508T3 (es) 2007-11-16
PT1870417E (pt) 2012-06-01
AU2005211548A1 (en) 2005-10-13
NO20020348L (no) 2002-01-23
JP2003505094A (ja) 2003-02-12
EP1196637A1 (en) 2002-04-17
EP1196637A4 (en) 2003-11-12
DE60034566D1 (de) 2007-06-06
EP1196637B1 (en) 2007-04-25
KR20020033743A (ko) 2002-05-07
JP5512463B2 (ja) 2014-06-04
CA2693274A1 (en) 2001-02-01
AU2005211548B2 (en) 2007-11-29
EP1870417A2 (en) 2007-12-26
PT1196637E (pt) 2007-07-04
EP1870417B9 (en) 2012-08-01
US6429300B1 (en) 2002-08-06
DK1196637T3 (da) 2007-07-30
JP4766808B2 (ja) 2011-09-07
JP2010284172A (ja) 2010-12-24
CY1113185T1 (el) 2016-04-13
US20060246549A1 (en) 2006-11-02
WO2001007657A1 (en) 2001-02-01
US7790421B2 (en) 2010-09-07
DK1870417T3 (da) 2012-07-16
US7078197B2 (en) 2006-07-18
AU781783B2 (en) 2005-06-16
HK1112007A1 (en) 2008-08-22

Similar Documents

Publication Publication Date Title
HK1045334A1 (zh) 缩氨酸受体结紮方法
WO1999057325A3 (en) Enzymes mixture
WO2003012119A3 (en) Nucleic acid amplification method
EP1293503A4 (en) Triazole derivatives
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2002366285A1 (en) Ides, an igg-degrading enzyme of streptococcus pyogenes
AU4332399A (en) Rna polymerase chain reaction
AU2002365122A1 (en) A method for engineering strand-specific, sequence-specific, dna-nicking enzymes
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
WO1995006764A3 (en) Oligonucleotides with rna cleavage activity
AU2576100A (en) Novel enzyme
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
WO2001000577A3 (en) Preparation of substituted piperidin-4-ones
AU1908100A (en) Isothermal nucleic acid amplification methods
AU2003248117A1 (en) Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
AU2002243235A1 (en) Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
AU2003245663A1 (en) Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates
AU2626699A (en) Self-replicating vector for dna immunization against hiv
WO2000059831A3 (en) Cleavable, water-soluble surfactants
AU2001252390A1 (en) Nucleic acid immunization
AU2001293697A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AU2438501A (en) Expression of proteins from amplified, immobilized nucleic acids
AU2002306218A1 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol B mass production system
AU1558200A (en) 1-hydroxy-3-sulfonoalkane-1,1-diphosphonous acids